Patents Assigned to Aventis Pharms S.A.
  • Crystalline form of (3R,4R)-4-[3-(S)-hydroxy-3-(6-methoxy-quinolin-4-yl)propyl]-1-[2-2thienylthio)ethyl] piperidine-3-carboxylic acid
    Publication number: 20040147554
    Abstract: The present invention comprises monohydrated form C of (3R,4R)-4-[3-(S)-hydroxy-3-(6-methoxyquinolin-4-yl)propyl]-1-[2-(2-thienylthio)ethyl]piperidine-3-carboxylic acid, represented by the structure 1
    Type: Application
    Filed: December 18, 2003
    Publication date: July 29, 2004
    Applicant: Aventis Pharms S.A.
    Inventors: Jacques Bourget, Marc Antoine Perrin, Bernd Janocha, Carole Neves, Pascal Billot, Sylvaine Lafont
  • Chemical derivatives and their application as antitelomerase agent
    Publication number: 20040053966
    Abstract: The present invention relates to cancer therapy and to novel anticancer agent having a mechanism of action which is quite specific. It also relates to novel chemical compounds as well as their therapeutic application in humans.
    Type: Application
    Filed: September 10, 2003
    Publication date: March 18, 2004
    Applicant: Aventis Pharms S.A.
    Inventors: Patrick Mailliet, Jean-Francois Riou, Jean-Louis Mergny, Abdelazize Laoui, Francois Lavelle, Odile Petitgenet
  • Medium for preserving biological materials
    Patent number: 6248588
    Abstract: The present invention relates to a medium allowing the preservation and cryopreservation of biological materials such as animal cells and viral particles that are directly injectable or reinjectable into an organism. A medium for preserving and/or freezing biological materials, including a saline solution, modified fluid gelatin and human serum albumin, is disclosed.
    Type: Grant
    Filed: December 14, 1998
    Date of Patent: June 19, 2001
    Assignee: Aventis Pharms S.A.
    Inventors: André Crespo, Henri Michel Soria